Search Results - jonathan+epstein

2 Results Sort By:
Histone Deacetylase and DNA Methyltransferase Inhibitors for Preventative Cardiac Care and Ischemic Injury Treatment
HDAC and DNMT Inhibitors such as Trichostatin A (TSA) and 5-aza-cytidine are preventative therapies and reduce myocardial infarct volume following cardiac events Technology Overview: Every 40 seconds, someone in the United States has a heart attack. Although several therapeutic options for heart attack recovery exist, ischemic injuries are responsible...
Published: 6/27/2024   |   Inventor(s): Jonathan Epstein, Peter Gruber, Ibrahim Abdullah
Keywords(s): Cardiovascular
Category(s): Technology Classifications > Therapeutics
Pharmaceutical therapeutic for the treatment of respiratory diseases
Histone deacetylase (HDAC) inhibitors such as Trichostatin A to treat bronchoconstrictive diseases including asthma and chronic obstructive pulmonary disorder (COPD) Technology Overview: Asthma and COPD are diseases of variable airflow obstruction affecting more than 40 million Americans. Although some patients respond to conventional therapies,...
Published: 6/27/2024   |   Inventor(s): Jonathan Epstein, Reynold Panettieri
Keywords(s):  
Category(s): Technology Classifications > Therapeutics